scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1055/S-2007-1019128 |
P698 | PubMed publication ID | 18256987 |
P2093 | author name string | Dean M Wingerchuk | |
P433 | issue | 1 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 56-68 | |
P577 | publication date | 2008-02-01 | |
P1433 | published in | Seminars in Neurology | Q15761563 |
P1476 | title | Current evidence and therapeutic strategies for multiple sclerosis | |
P478 | volume | 28 |
Q92163960 | Acute disseminated encephalomyelitis following varicella-zoster virus infection: Case report of effective treated both in clinical symptom and neuroimaging |
Q42004497 | Acute disseminated encephalomyelitis: Treatment guidelines |
Q37922644 | Adherence and persistence among multiple sclerosis patients after one immunomodulatory therapy failure: retrospective claims analysis |
Q82564448 | Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS |
Q33377548 | Cognitive changes in multiple sclerosis |
Q33382919 | Daclizumab treatment for multiple sclerosis |
Q40891679 | Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation |
Q40760409 | IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis |
Q36683082 | Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis |
Q46276291 | Oral fumarate for relapsing-remitting multiple sclerosis. |
Q38024650 | Rehabilitation interventions in multiple sclerosis: an overview |
Q92297995 | SUCCESSFUL TREATMENT OF ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM) BY PROMPT USAGE OF IMMUNOGLOBULINS - CASE REPORT AND REVIEW OF THE LITERATURE |
Q37442077 | Successful management of a neurology infusion practice |
Q36653657 | Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis |
Q36261669 | Transplantation of olfactory ensheathing cells promotes partial recovery in rats with experimental autoimmune encephalomyelitis |
Q34160752 | Use of an online community to develop patient-reported outcome instruments: the Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). |
Search more.